生物素文獻薈萃報告 — 2026 年 4 月
摘要
本月共收錄 生物素 相關文獻 4094 篇,其中 Level 1 證據(Meta-Analysis/Systematic Review)73 篇,RCT 25 篇。
證據等級分布
| 證據等級 | 文獻數 | 佔比 |
|---|---|---|
| Level 1 (Meta-Analysis/Systematic Review) | 73 | 1.8% |
| Level 2 (RCT) | 25 | 0.6% |
| Level 3 (Clinical Trial) | 16 | 0.4% |
| Level 4 (Observational) | 11 | 0.3% |
| Level 5 (Review/Case Report/Other) | 3969 | 96.9% |
功效分類統計
| 功效分類 | 中文 | 文獻數 | 佔比 |
|---|---|---|---|
| other | 其他 | 2315 | 56.5% |
| immune | 免疫調節 | 496 | 12.1% |
| metabolic | 代謝 | 379 | 9.3% |
| cardiovascular | 心血管 | 321 | 7.8% |
| anti_aging | 抗衰老 | 317 | 7.7% |
| energy | 活力 | 293 | 7.2% |
| cognitive | 認知功能 | 290 | 7.1% |
| musculoskeletal | 肌肉骨骼 | 225 | 5.5% |
| digestive | 消化 | 182 | 4.4% |
| skin | 皮膚 | 131 | 3.2% |
| sexual | 性功能 | 44 | 1.1% |
成分搭配統計
| 成分 | 文獻數 |
|---|---|
| EPA | 507 |
| iron | 461 |
| NAC | 122 |
| fiber | 67 |
| calcium | 56 |
| stem cell | 47 |
| collagen | 47 |
| glutathione | 41 |
| zinc | 38 |
| creatine | 18 |
成分組合分析
以下列出最常被共同研究的成分組合:
| 成分組合 | 共同出現文獻數 |
|---|---|
| EPA + iron | 61 |
| NAC + iron | 24 |
| EPA + NAC | 18 |
| calcium + iron | 15 |
| EPA + collagen | 13 |
| exosome + exosomes | 12 |
| EPA + fiber | 10 |
| EPA + calcium | 10 |
| EPA + stem cell | 10 |
| glutathione + iron | 10 |
成分功效分析
以下列出主要成分在各功效領域的研究文獻數:
| 成分 | 總文獻 | 其他 | 免疫調節 | 代謝 | 抗衰老 | 心血管 | 肌肉骨骼 |
|---|---|---|---|---|---|---|---|
| EPA | 507 | 236 | 89 | 60 | 55 | 61 | 41 |
| iron | 461 | 262 | 70 | 41 | 32 | 22 | 20 |
| NAC | 122 | 68 | 18 | 12 | 4 | 13 | 3 |
| fiber | 67 | 29 | 6 | 6 | 5 | 4 | 12 |
| calcium | 56 | 20 | 8 | 10 | 5 | 2 | 13 |
| stem cell | 47 | 7 | 18 | 5 | 7 | 3 | 14 |
| collagen | 47 | - | 17 | 6 | 10 | 4 | 12 |
| glutathione | 41 | 12 | 16 | 12 | 7 | 11 | 2 |
研究類型分布
| 研究類型 | 文獻數 | 佔比 |
|---|---|---|
| Meta-Analysis | 53 | 1.3% |
| Systematic Review | 20 | 0.5% |
| RCT | 25 | 0.6% |
| Clinical Trial | 16 | 0.4% |
| Observational | 11 | 0.3% |
| Review | 97 | 2.4% |
| Case Report | 60 | 1.5% |
| Other | 3812 | 93.1% |
近期重要文獻
Level 1 證據(Meta-Analysis / Systematic Review)
- The association between toll-like receptor gene polymorphism and Helicobacter pylori infection risk: A systematic review and meta-analysis. — Medicine, 2026-02-20
- 功效分類:other
- Health-related quality of life after free flap reconstruction of maxillary defects: a systematic review and meta-analysis. — Oral oncology, 2026-03-18
- 功效分類:other
- Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients with Extra-Renal Systemic Lupus Erythematosus - A Systematic Review & Meta-analysis. — Arthritis care & research, 2026-03-09
- 功效分類:other
- Timing-dependent effects of melatonin supplementation on exercise performance and exercise-induced muscle damage: a systematic review and meta-analysis. — Frontiers in nutrition, 2026-01-01
- 功效分類:musculoskeletal
- Comparative Efficacy and Safety of Hybrid Endoscopic Submucosal Dissection for Colorectal Neoplasia: A Systematic Review and Meta-Analysis. — JGH open : an open access journal of gastroenterology and hepatology, 2026-03-01
- 功效分類:other
Level 2 證據(RCT)
- Sivelestat and Incidence of Acute Respiratory Distress Syndrome After Cardiovascular Surgery: A Randomized Clinical Trial. — JAMA network open, 2026-03-02
- 功效分類:cardiovascular, immune
- Efficacy of vaginal androgen combined with pelvic floor muscle training for stress urinary incontinence in postmenopausal women: a randomized-controlled trial. — The Canadian journal of urology, 2026-02-28
- 功效分類:musculoskeletal
- Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention. — Lancet (London, England), 2026-03-21
- 功效分類:anti_aging, metabolic, digestive
- Effects of Cipepofol on Cardiac Depolarization and Repolarization in Healthy Subjects: A Single-Center, Randomized, Placebo and Positive-Controlled Thorough QT Study. — Drug design, development and therapy, 2026-01-01
- 功效分類:cardiovascular
- Dexmedetomidine Plus Stellate Ganglion Block Improves Postoperative Sleep Quality in Elderly Hip Arthroplasty Patients: A Randomized Controlled Trial. — Drug design, development and therapy, 2026-01-01
- 功效分類:other
免責聲明
本網站內容由 AI 自動生成,基於各國官方公開資料庫的產品登記資訊。 報告內容僅供參考,不構成醫療建議、投資建議或商業建議。 如有健康問題,請諮詢專業醫療人員。
產品統計以資料庫登記為準,不代表實際市場銷售狀況。 各國監管制度不同,跨國比較應考慮法規差異。